Guerbet SA (EPA:GBT)
6.04
+0.23 (3.96%)
Oct 22, 2026, 5:35 PM CEST
Guerbet Revenue
Guerbet had revenue of 379.19M EUR in the half year ending June 30, 2026, a decrease of -9.54%. This brings the company's total for the last twelve months to 777.88M, down -3.93% year-over-year. In the year 2025, Guerbet had annual revenue of 786.44M, down -6.50%. That makes Guerbet the 8,167th largest company in the world by revenue and 157th in France.
Revenue (ttm)
777.88M
Revenue Growth
-3.93%
P/S Ratio
0.10
Revenue / Employee
292.83K
Employees
2,746
Market Cap
75.78M
Revenue by Geography
- Emea 343.66M 43.8%
- Americas 233.02M 29.7%
- Asia 207.89M 26.5%
Fiscal year ended Dec 31, 2025 See the full Guerbet breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 786.44M | -54.65M | -6.50% |
| Dec 31, 2024 | 841.09M | 55.40M | 7.05% |
| Dec 31, 2023 | 785.69M | 32.42M | 4.30% |
| Dec 31, 2022 | 753.28M | 21.20M | 2.90% |
| Dec 31, 2021 | 732.07M | 19.78M | 2.78% |
| Dec 31, 2020 | 712.30M | -104.61M | -12.81% |
| Dec 31, 2019 | 816.91M | 27.30M | 3.46% |
| Dec 31, 2018 | 789.60M | -17.52M | -2.17% |
| Dec 31, 2017 | 807.12M | 31.35M | 4.04% |
| Dec 31, 2016 | 775.77M | 287.04M | 58.73% |
| Dec 31, 2015 | 488.74M | 79.78M | 19.51% |
| Dec 31, 2014 | 408.96M | 19.29M | 4.95% |
| Dec 31, 2013 | 389.67M | -13.83M | -3.43% |
| Dec 31, 2012 | 403.50M | 25.66M | 6.79% |
| Dec 31, 2011 | 377.83M | 25.26M | 7.16% |
| Dec 31, 2010 | 352.58M | 17.10M | 5.10% |
| Dec 31, 2009 | 335.48M | 14.70M | 4.58% |
| Dec 31, 2008 | 320.78M | 15.24M | 4.99% |
| Dec 31, 2007 | 305.55M | 16.14M | 5.58% |
| Dec 31, 2006 | 289.41M | 19.93M | 7.40% |
| Dec 31, 2005 | 269.48M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Eurobio Scientific Société anonyme | 172.26M |
| Biosynex | 95.19M |
| Diagnostic Medical Systems | 51.41M |
| Novacyt | 25.31M |
| Median Technologies | 23.47M |
| Implanet | 13.80M |
| Mauna Kea Technologies | 8.38M |
| SpineGuard | 3.09M |
Guerbet News
- 13 hours ago - Guerbet Earnings release: Q3 2026 - Filings
- 24 days ago - Guerbet Earnings release: H1 2026 - Filings
- 24 days ago - Guerbet Slides: H1 2026 - Filings
- 24 days ago - Guerbet Quarterly report: H1 2026 - Filings
- 3 months ago - Guerbet Earnings release: Q2 2026 - Filings
- 6 months ago - Q1 2026 revenue - Benzinga
- 6 months ago - Guerbet Earnings release: Q1 2026 - Filings
- 7 months ago - Guerbet Annual report: H2 2025 - Filings